Freedom Investment Management Inc. Invests $157,000 in SIGA Technologies, Inc. (NASDAQ:SIGA)

Freedom Investment Management Inc. purchased a new position in SIGA Technologies, Inc. (NASDAQ:SIGA) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 23,273 shares of the company’s stock, valued at approximately $157,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Advantage Alpha Capital Partners LP purchased a new stake in SIGA Technologies during the 3rd quarter worth approximately $276,000. Larson Financial Group LLC acquired a new stake in shares of SIGA Technologies during the third quarter worth approximately $30,000. Algert Global LLC bought a new stake in shares of SIGA Technologies in the third quarter worth $464,000. Charles Schwab Investment Management Inc. raised its holdings in SIGA Technologies by 5.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 507,262 shares of the company’s stock valued at $3,424,000 after acquiring an additional 24,101 shares in the last quarter. Finally, Foundry Partners LLC bought a new position in SIGA Technologies during the 3rd quarter valued at $2,801,000. Hedge funds and other institutional investors own 55.40% of the company’s stock.

SIGA Technologies Price Performance

Shares of SIGA stock opened at $7.28 on Monday. The firm has a fifty day moving average of $6.94 and a two-hundred day moving average of $7.85. The firm has a market cap of $519.83 million, a P/E ratio of 6.07 and a beta of 0.89. SIGA Technologies, Inc. has a 1-year low of $4.26 and a 1-year high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The business had revenue of $10.01 million during the quarter. On average, sell-side analysts expect that SIGA Technologies, Inc. will post 1.04 EPS for the current year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.